Hextend® is a sterile medical IV solution used as a blood plasma volume expander to replace blood volume lost in routine surgery, emergency trauma surgery and other applications, a condition known as hypovolemia (low blood volume). Hextend’s unique formulation contains a modified form of starch (6% hetastarch) suspended in a balanced electrolyte solution. The product more closely mirrors the electrolyte balance of blood than other products that contain 6% hetastarch in simple salt (sodium chloride, or saline) solutions. Hextend is not a substitute for blood or plasma.

Please see the Hextend Product Insert for complete prescribing information.
Hextend is manufactured and distributed in the U.S. by Hospira, Inc. and in South Korea by CJ Healthcare Corporation, under exclusive licensing agreements.